Dolores Schendel

Dolores Schendel

Company: Medigene AG

Job title: CEO & CSO

Seminars:

Panel Discussion: Optimizing Development of Combination Approaches to Overcome the Solid Tumor Microenvironment 10:30 am

Exploring how to train T cells to overcome immune defence and survive in the low-nutrient, acidic and hypoxic tumour microenvironment Utilizing anti-PD1 antibody fragments secreted from T-cells after tumor interaction to overcome the local suppressive environment Profiling metabolic TME immuno-suppressive mechanisms through use of novel technology platformsRead more

day: Day Two

Helping TCR-Ts Meet the Challenges of the TME 10:00 am

Antigens/Epitopes contribute to success TCR sensitivity is of critical importance Enhanced TCR-Ts can overcome multiple hurdlesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.